MG2A

General Information


DRACP ID  DRACP05713

Peptide Name   MG2A

Sequence  GIGKFLHSAKKFGKAFVGEIMNSGGKKWKMRRNQFWVKVQRG

Sequence Length  42

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C222H351N67O51S2

Absent amino acids  CDPTY

Common amino acids  K

Mass  557025

Pl  12.34

Basic residues  12

Acidic residues  1

Hydrophobic residues  14

Net charge  11

Boman Index  -7343

Hydrophobicity  -65.71

Aliphatic Index  53.33

Half Life 
  Mammalian: 1.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  11000

Absorbance 280nm  268.29

Polar residues  11

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23286306

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2774

DRACP is developed by Dr.Zheng's team.